The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
“Mini-mental state”
1975 • 82,784 citations
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
1969 • 16,855 citations
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 • 5,422 citations
A new rating scale for Alzheimer's disease
1984 • 3,948 citations
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
1979 • 445 citations
Tacrine in Alzheimer's disease
1991 • 355 citations
Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies
1991 • 327 citations
Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT)
1983 • 296 citations
Serotonin, memory, and the aging brain
1991 • 287 citations
Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
1980 • 254 citations
Neurotransmitter changes in alzheimer's disease: Implications to diagnostics and therapy
1990 • 225 citations
Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease
1990 • 207 citations
The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia
1969 • 125 citations
Dopaminergic system and monoamine oxidase-B Activity in Alzheimer's disease
1988 • 116 citations
Neuropsychological Effects of L-Deprenyl in Alzheimerʼs Type Dementia
1990 • 114 citations
Neurochemical aspects on aging and diseases with cognitive impairment
1990 • 104 citations
Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease
1988 • 86 citations
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
1991 • 61 citations
Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons
1987 • 60 citations
Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase
1989 • 41 citations
Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis
1990 • 32 citations
Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain
1990 • 27 citations
Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia
1987 • 14 citations
Cholinergic Basis for Alzheimer Therapy
1993 • 9 citations
Enhanced monoaminergic neurotransmission by desglycinamide-arginine-vasopressin in human subjects
1987 • 8 citations
Swedish Experiences of THA Therapy in Alzheimer’s Disease
1991 • 2 citations
Cited By (0)
No citing papers found in database